Seer to Present at the BofA Securities 2022 Healthcare Conference
April 28 2022 - 4:05PM
Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing
a disruptive new platform for proteomics, today announced that the
company will be participating in the upcoming BofA Securities 2022
Healthcare Conference in Las Vegas, Nevada.
Seer’s management is scheduled to participate in
a fireside chat on Tuesday, May 10 at 4:40 p.m. Pacific Time / 7:40
p.m. Eastern Time. A live webcast of the virtual session will be
available on the Investor section of Seer’s website at
investor.seer.bio. An archived replay will be available on the
company’s website following the conference.
About Seer Seer™ is a life
sciences company developing transformative products that open a new
gateway to the proteome. Seer’s Proteograph™ Product Suite is an
integrated solution that includes proprietary engineered
nanoparticles, consumables, automation instrumentation and software
to perform deep, unbiased proteomic analysis at scale in a matter
of hours. Seer designed the Proteograph workflow to be efficient
and easy to use, leveraging widely adopted laboratory
instrumentation to provide a decentralized solution that can be
incorporated by nearly any lab. Seer’s Proteograph Product Suite is
for research use only and is not intended for diagnostic
procedures. For more information, please
visit www.seer.bio.
Investor ContactCarrie
Mendivilinvestor@seer.bio
Media ContactKaren Possematopr@seer.bio
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jun 2024 to Jul 2024
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jul 2023 to Jul 2024